Woodmont Investment Counsel LLC Sells 2,791 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Woodmont Investment Counsel LLC trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 13.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 18,101 shares of the healthcare conglomerate’s stock after selling 2,791 shares during the period. Woodmont Investment Counsel LLC’s holdings in UnitedHealth Group were worth $9,156,000 as of its most recent filing with the SEC.

Other hedge funds also recently modified their holdings of the company. NewSquare Capital LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at about $25,000. AlphaMark Advisors LLC acquired a new position in UnitedHealth Group during the 4th quarter worth approximately $30,000. Promus Capital LLC acquired a new stake in UnitedHealth Group in the fourth quarter valued at approximately $32,000. RPg Family Wealth Advisory LLC acquired a new position in shares of UnitedHealth Group during the third quarter worth approximately $37,000. Finally, Pillar Financial Advisors LLC bought a new stake in UnitedHealth Group during the 4th quarter valued at $40,000. Institutional investors own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the stock. Wells Fargo & Company reduced their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Barclays lowered their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday, January 17th. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective on the stock in a report on Friday, January 10th. Finally, Piper Sandler cut their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Twenty equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $629.32.

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The stock was bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE UNH opened at $517.72 on Monday. The company’s 50 day moving average is $510.19 and its 200-day moving average is $546.71. The firm has a market cap of $473.57 billion, a P/E ratio of 33.40, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same period in the previous year, the business earned $5.83 earnings per share. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. Sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.62%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.